Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Dr Ingeborgh VAN DEN BORN

In this page

Member info

Dr Ingeborgh VAN DEN BORN

Representative

Netherlands

Working Group(s): Retinal Rare Eye Diseases (WG1), Registries & Epidemiology (TWG7), Research (TWG8)

Team

Dr Tanya Lushchyk

Netherlands

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Judith van Everdingen

Netherlands

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Dzenita Smailhodzic

Netherlands

Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr Martha Tjon-Fo-Sang

Netherlands

Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)
See more

HCP Center

The Rotterdam Eye Hospital (established in 1874) is the largest provider of ophthalmic care in The Netherlands. We provide the highest quality of eye...

contact

The Rotterdam Eye Hospital, Rotterdam, Netherlands

Schiedamse Vest 180
3011 BH Rotterdam
Netherlands

Clinical trials

NCT05158296 Active, Not recruiting

A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Interventional
See the trial
voir la fiche
NCT05633576 Completed

Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)

Interventional
See the trial
voir la fiche

NCT02796274 Completed

Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).

Interventional
See the trial
voir la fiche
NCT02575430 Completed

Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.

Observational
See the trial
voir la fiche
NCT05642312 Recruiting, Active

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Interventional
See the trial
voir la fiche

Scientific publications

Novel Clinical Observations and Genetic Spectrum in 340 Patients

In most patients, XLRS showed a slow deterioration starting in the second decade of life, suggesting an optimal window of opportunity for...

The Natural History of Leber Congenital Amaurosis and ConeeRod Dystrophy Associated with Variants in the GUCY2D Gene

Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy...

Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network – EVICR.net

This second multinational survey on management of IRDs in Europe highlights persistent important differences in the number of IRD patients managed...

PDF - 1 MB

Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey

An electronic survey questionnaire with 48 questions specifically addressing RPE65-IRD (2019 survey 35) was developed and sent by June 2021 to 95...

PDF - 665 KB

Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis

Our data indicate that treatment with (oral) CAI may be beneficial for short-term management of CFC in patients with...